Ketamine Infusion for Obsessive-Compulsive Disorder

NCT01349231 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Obsessive-compulsive Disorder

Interventions

DRUG: ketamine

Sponsor

Yale University

Collaborators

[object Object]